Galapagos N.V.

GLPGNASDAQHealthcare

$27.98

+$0.47(+1.71%)

Market Cap$1.8B

P/E Ratio—

52W High$37.78

52W Low$24.74

Avg Volume153K

Open$27.50

Beta0.25

Employees Ownership Insider Trades

Galapagos N.V. (GLPG) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · GLPG · as of Mar 26, 2026

Latest filing snapshot

452

-252-35.80%vs prior year

Galapagos N.V. (GLPG) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global

Total Employees

452

Change (1Y)

-252

Growth % (1Y)

-35.80%

Revenue / Employee

$2.46M

Net Income / Employee

$709.9K

Market Cap

$1.8B

GLPG Employee Count

2015 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-26	2025-12-31	452	-252	-35.80%
2025-03-27	2024-12-31	704	-419	-37.31%
2024-03-28	2023-12-31	1,123	-215	-16.07%
2023-03-23	2022-12-31	1,338	+29	+2.22%
2022-03-24	2021-12-31	1,309	+5	+0.38%
2021-03-25	2020-12-31	1,304	+301	+30.01%
2020-03-27	2019-12-31	1,003	+278	+38.34%
2019-03-29	2018-12-31	725	+125	+20.83%
2018-03-23	2017-12-31	600	+92	+18.11%
2017-03-23	2016-12-31	508	+73	+16.78%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Denali Therapeutics Inc.

443$3.1B #4

COGT

Cogent Biosciences, Inc.

205$5.3B #5

GPCR

Structure Therapeutics Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · GLPG peer comparison

About GLPG employees

GLPG Employees · Headcount

Galapagos N.V. (GLPG) employee data is sourced from the annual SEC 20-F filing. As of 2025, Galapagos N.V. had 452 full-time employees globally. Full-time employees only. Global consolidated headcount.

Galapagos N.V. employs 452 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $2.46M, reflecting the company's operational efficiency.

Galapagos N.V.'s workforce decreased by 252 (35.80%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Galapagos N.V.'s revenue per employee of $2.46M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

GLPG Employees · 5 questions

As of the latest SEC 20-F filing (2025), Galapagos N.V. had 452 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Galapagos N.V. employee counthow many employees does Galapagos N.V. haveGLPG total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-26